161 related articles for article (PubMed ID: 12702895)
1. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.
Spigset O; Hägg S; Bate A
Int Clin Psychopharmacol; 2003 May; 18(3):157-61. PubMed ID: 12702895
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
Augustin BG; Cold JA; Jann MW
Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
Goldberg RJ
Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of the new antidepressants.
Nelson JC
J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
[TBL] [Abstract][Full Text] [Related]
5. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Masand PS; Gupta S
Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
[TBL] [Abstract][Full Text] [Related]
6. New antidepressant drugs and the treatment of depression in the medically ill patient.
Stoudemire A
Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone and venlafaxine: two new agents for the treatment of depression.
Goldberg RJ
J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
[TBL] [Abstract][Full Text] [Related]
8. [Applications and safety of modern antidepressants in patients with liver diseases].
Dubarek W; Kucia K
Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
[TBL] [Abstract][Full Text] [Related]
9. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).
Hedenmalm K; Sundström A; Spigset O
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):719-25. PubMed ID: 16783834
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Preskorn SH
J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
[TBL] [Abstract][Full Text] [Related]
11. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
de Abajo FJ; García-Rodríguez LA
Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Horst WD; Preskorn SH
J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
[TBL] [Abstract][Full Text] [Related]
13. Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
Strombom I; Wernicke JF; Seeger J; D'Souza DN; Acharya N
Curr Drug Saf; 2008 May; 3(2):154-62. PubMed ID: 18690993
[TBL] [Abstract][Full Text] [Related]
14. [Selective serotonin uptake inhibitors and pancreatitis].
Kvande KT; Madsen S
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):177-8. PubMed ID: 11475194
[TBL] [Abstract][Full Text] [Related]
15. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Sussman N; Ginsberg DL; Bikoff J
J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
[TBL] [Abstract][Full Text] [Related]
16. Hyponatremia with venlafaxine.
Masood GR; Karki SD; Patterson WR
Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
[TBL] [Abstract][Full Text] [Related]
17. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD
BMC Gastroenterol; 2015 Oct; 15():134. PubMed ID: 26467777
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions of antidepressants.
Richelson E
J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
